Last reviewed · How we verify

NCT04837638: FH-CAC

Diet Quality and Coronary Artery Calcification in Adults With Heterozygous Familial Hypercholesterolemia

Status unknown Last updated 13 March 2024
What this trial tests

trial testing Diet in Hypercholesterolemia, Familial in 258 participants. Status unknown.

Timeline
1 July 2021
Primary endpoint
31 December 2023
31 December 2024

Quick facts

Lead sponsorLaval University
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment258
Start date1 July 2021
Primary completion31 December 2023
Estimated completion31 December 2024
Sites1 location across Canada

Drugs / interventions tested

Conditions studied

Sponsor

Laval University

Who can join

Adults 18 to 99, any sex, with Hypercholesterolemia, Familial or Calcification; Heart. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The overarching objective is to evaluate the relationship between diet and coronary artery calcification in patients with heterozygous familial hypercholesterolemia (HeFH). We will recruit adults with HeFH. They will have to complete questionnaires on diet, medication and lifestyle. Coronary artery calcification will be measured in each patient using a CT scan. Physiological and biochemical data will be collected.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Diet

Trials testing the same drug.

Other recruiting trials for Hypercholesterolemia, Familial

Currently open trials in the same condition.

Other Laval University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04837638.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing